The COVID-19 pandemic has profoundly influenced public trust in vaccines, particularly those authorized under Emergency Use Authorization (EUA).
In light of the recent monkeypox (mpox) outbreak, the primary aim of this study is to uncover how experiences with the COVID-19 vaccination have shaped public trust in hypothetical EUA vaccines for mpox.
